References
Kudou M, Shiozaki A, Yamazato Y, et al. The expression and role of TRPV2 in esophageal squamous cell carcinoma. Sci Rep. 2019;9(1):16055.
Nabissi M, Morelli MB, Amantini C, et al. TRPV2 channel negatively controls glioma cell proliferation and resistance to Fas-induced apoptosis in ERK-dependent manner. Carcinogenesis. 2010;31(5):794–803.
Kato S, Shiozaki A, Kudou M, et al. TRPV2 promotes cell migration and invasion in gastric cancer via the transforming growth factor-β signaling pathway. Ann Surg Oncol. 2021. https://doi.org/10.1245/s10434-021-11132-5.
Shiozaki A, Kudou M, Ichikawa D, et al. Esophageal cancer stem cells are suppressed by tranilast, a TRPV2 channel inhibitor. J Gastroenterol. 2018;53(2):197–207.
Shiozaki A, Kudou M, Fujiwara H, et al. Clinical safety and efficacy of neoadjuvant combination chemotherapy of tranilast in advanced esophageal squamous cell carcinoma: phase I/II study (TNAC). Medicine. 2020;99(50):e23633.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Shunji Kato, Atsushi Shiozaki, and Eigo Otsuji declare that they have no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kato, S., Shiozaki, A. & Otsuji, E. ASO Author Reflections: TRPV2 and Gastric Cancer. Ann Surg Oncol 29, 2957–2958 (2022). https://doi.org/10.1245/s10434-021-11186-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-021-11186-5